- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Spinocerebellar Ataxia 1 in Korea, Democratic People's Republic of
Total 71 results
-
HLB Pharmaceutical Co., Ltd.CompletedSpinocerebellar DegenerationKorea, Republic of
-
Samsung Medical CenterCompletedSpinocerebellar Ataxias | Multiple System Atrophy, Cerebellar Variant (Disorder)Korea, Republic of
-
Seelos Therapeutics, Inc.TerminatedSpinocerebellar Ataxia Type 3United States, Spain, Korea, Republic of, Australia, United Kingdom, Brazil, Germany, Portugal
-
Seoul National University HospitalCompletedAtaxia, Cerebellar | Ataxia, ProgressiveKorea, Republic of
-
Bristol-Myers SquibbCompleted
-
Yonsei UniversityRecruitingType 1 DiabetesKorea, Republic of
-
Samsung Medical CenterUnknownType 1 Diabetes MellitusKorea, Republic of
-
Samsung Medical CenterCompletedType 1 DiabetesKorea, Republic of
-
Seoul National University HospitalMedtronicRecruitingType 1 DiabetesKorea, Republic of
-
Yonsei UniversityNot yet recruitingType 1 Diabetes MellitusKorea, Republic of
-
Korea Otsuka Pharmaceutical Co., Ltd.CompletedSchizophrenia | Bipolar 1 DisorderKorea, Republic of
-
Daewoong Pharmaceutical Co. LTD.CompletedPhase 1 Study, Healthy VolunteersKorea, Republic of
-
Young Shin SongCompletedType 1 Diabetes MellitusKorea, Republic of
-
Handok Inc.CMG Pharmaceutical Co. LtdCompletedSolid Tumor, Adult | Phase 1Korea, Republic of
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | Diabetes | Diabetes Mellitus, Type 1Korea, Republic of
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | Diabetes | Diabetes Mellitus, Type 1Korea, Republic of
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | Diabetes | Diabetes Mellitus, Type 1Korea, Republic of
-
HucircadianPusan National University Hospital; Korea University Guro Hospital; Korea University... and other collaboratorsRecruitingMajor Depressive Disorder | Bipolar 1 Disorder | Bipolar II DisorderKorea, Republic of
-
Seoul National University HospitalRecruitingType 1 DiabetesKorea, Republic of
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | Diabetes | Diabetes Mellitus, Type 1Korea, Republic of
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | Diabetes | Diabetes Mellitus, Type 1Korea, Republic of
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | Diabetes | Diabetes Mellitus, Type 1Korea, Republic of
-
Samsung Medical CenterMinistry of Trade, Industry & Energy, Republic of Korea; Korea Evaluation Institute... and other collaboratorsCompletedDiabetes Mellitus | Insulin-dependent Diabetes Mellitus | Insulin HypoglycemiaKorea, Republic of
-
Yonsei UniversityNot yet recruitingNewly Diagnosed Type 1 and Type 2 Diabetes and PrediabetesKorea, Republic of
-
ENCellRecruitingCharcot-Marie-Tooth Disease Type 1AKorea, Republic of
-
Kyowa Kirin Korea Co., Ltd.TerminatedPhase 1 Portion : Non Small Cell Lung Cancer(NSCLC), Small Cell Lung Cancer(SCLC), Mesothelioma | Phase 2 Portion : Small Cell Lung Cancer(SCLC)Korea, Republic of
-
CinnagenCompletedBioequivalence | Phase 1Iran, Islamic Republic of
-
Cellatoz Therapeutics, IncActive, not recruitingCharcot Marie Tooth Disease, Type 1Korea, Republic of
-
AryoGen Pharmed Co.CompletedBioequivalence | Phase 1Iran, Islamic Republic of
-
Semnan University of Medical SciencesCompletedType 2 Diabetes Mellitus | Type 1 Diabetes MellitusIran, Islamic Republic of
-
Singapore General HospitalCompletedAngioimmunoblastic T-cell Lymphoma | Hepatosplenic T-cell Lymphoma | Peripheral T-cell Lymphoma (Not Otherwise Specified) | Extranodal NK/T-cell Lymphoma Nasal Type | Enteropathy- Type T-cell Lymphoma | Anaplastic Large Cell Lymphoma (ALCL) (ALK-1 Negative) | Relapsed ALCL (ALK-1 Positive) Post...Singapore, Malaysia, Korea, Republic of
-
Royan InstituteTehran University of Medical Sciences; Iranian Stem Cell CouncilUnknownDiabetes Mellitus | Diabetes Mellitus, Type 1 | Diabetes Mellitus, Insulin-DependentIran, Islamic Republic of
-
Nahid ZarifsanaieyCompletedDiabetes Mellitus, Type 1 | Self-ManagementIran, Islamic Republic of
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | Diabetes | Diabetes Mellitus, Type 1Macedonia, The Former Yugoslav Republic of
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | Diabetes | Diabetes Mellitus, Type 1Macedonia, The Former Yugoslav Republic of
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | Diabetes | Diabetes Mellitus, Type 1Korea, Republic of
-
CinnagenCompletedMucopolysaccharidosis Type 1Iran, Islamic Republic of
-
Ascendis Pharma Oncology Division A/SRecruitingAdvanced Solid Tumor | Metastatic Solid Tumor | Platinum-resistant Ovarian Cancer | Locally Advanced Solid Tumor | Post Anti-PD-1 Melanoma | 2L+ Cervical Cancer | Neoadjuvant Melanoma | Neoadjuvant Non-Small Cell Lung Cancer | Post Anti-PD-(L)1 Non-Small Cell Lung Cancer | Post Anti-PD-(L)1 Small Cell...United States, Australia, Korea, Republic of
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | Diabetes | Diabetes Mellitus, Type 1Israel, Korea, Republic of, Turkey, Italy, Belgium, United Kingdom, Greece, Ireland, Sweden, Denmark, Finland, France, Czech Republic
-
SanofiCompletedDiabetes Mellitus, Type 1France, Australia, Spain, Sweden, United States, Austria, Hungary, Israel, Italy, United Kingdom, Korea, Republic of, Netherlands
-
Novartis PharmaceuticalsCompletedLow and Int 1-risk Myelodysplastic SyndromeGermany, Canada, Korea, Republic of, Sweden, Spain, China, Argentina, Italy, United Kingdom, Algeria
-
CSL BehringRecruitingAcute-graft-versus-host DiseaseUnited States, Korea, Republic of, Spain, Australia, Germany, Italy, Turkey, Japan
-
Andromeda Biotech Ltd.CompletedType 1 Diabetes MellitusUnited States, Russian Federation, Israel, Spain, Lithuania, Germany, Austria, Belarus, Canada, Czech Republic, Finland, Hungary, Italy, Poland
-
Novo Nordisk A/SCompletedDiabetes | Diabetes Mellitus, Type 1France, Denmark, Finland, Russian Federation, Macedonia, The Former Yugoslav Republic of, Hungary, Bulgaria, United Kingdom, Turkey, Czech Republic, Poland
-
BeiGeneRecruitingLocally Advanced or Metastatic Solid Tumors for Phase 1,Dose Escalation and Phase 2 Safety Lead-in, HNSCC, NSCLC and RCC Participants for Phase 2Australia, United States, Spain, France, Italy, Korea, Republic of, Poland
-
TakedaTerminatedNarcolepsy Type 1 (NT 1)United States, Italy, Finland, Canada, Hungary, Czechia, France, Japan, Korea, Republic of, Spain
-
Gilead SciencesCompletedHIV-1 InfectionRussian Federation, United States, Thailand, Uganda, Puerto Rico, Dominican Republic
-
Novo Nordisk A/SCompletedDiabetes | Diabetes Mellitus, Type 1France, Denmark, Finland, Russian Federation, Macedonia, The Former Yugoslav Republic of, Hungary, Bulgaria, United Kingdom, Turkey, Poland, Czech Republic
-
Gilead SciencesRecruitingHIV-1-infectionJapan, Germany, France, United States, Spain, Korea, Republic of, South Africa, Australia, Argentina, Canada, Dominican Republic, Italy, Puerto Rico, Taiwan, United Kingdom
-
Gilead SciencesRecruitingHIV-1-infectionUnited States, Thailand, Dominican Republic